nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A3—Metformin—polycystic ovary syndrome	0.309	0.475	CbGbCtD
Procainamide—SLC22A2—Metformin—polycystic ovary syndrome	0.183	0.281	CbGbCtD
Procainamide—SLC22A1—Metformin—polycystic ovary syndrome	0.159	0.244	CbGbCtD
Procainamide—Function kidney decreased—Metformin—polycystic ovary syndrome	0.0158	0.228	CcSEcCtD
Procainamide—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.00966	0.139	CcSEcCtD
Procainamide—DNMT1—embryo—polycystic ovary syndrome	0.0035	0.0338	CbGeAlD
Procainamide—Sunitinib—INSR—polycystic ovary syndrome	0.00328	0.342	CrCbGaD
Procainamide—Lightheadedness—Metformin—polycystic ovary syndrome	0.00309	0.0446	CcSEcCtD
Procainamide—SCN7A—adipose tissue—polycystic ovary syndrome	0.00301	0.029	CbGeAlD
Procainamide—DNMT1—adrenal cortex—polycystic ovary syndrome	0.00287	0.0277	CbGeAlD
Procainamide—CYP2D6—urine—polycystic ovary syndrome	0.00287	0.0277	CbGeAlD
Procainamide—SCN7A—adrenal gland—polycystic ovary syndrome	0.0027	0.026	CbGeAlD
Procainamide—Sunitinib—FLT4—polycystic ovary syndrome	0.00268	0.279	CrCbGaD
Procainamide—Renal impairment—Metformin—polycystic ovary syndrome	0.00263	0.038	CcSEcCtD
Procainamide—DNMT1—endometrium—polycystic ovary syndrome	0.00256	0.0247	CbGeAlD
Procainamide—Lethargy—Metformin—polycystic ovary syndrome	0.00256	0.0369	CcSEcCtD
Procainamide—SCN7A—female gonad—polycystic ovary syndrome	0.00251	0.0243	CbGeAlD
Procainamide—SCN9A—pituitary gland—polycystic ovary syndrome	0.00236	0.0228	CbGeAlD
Procainamide—DNMT1—uterus—polycystic ovary syndrome	0.00236	0.0228	CbGeAlD
Procainamide—SCN9A—adipose tissue—polycystic ovary syndrome	0.00235	0.0227	CbGeAlD
Procainamide—SCN7A—endocrine gland—polycystic ovary syndrome	0.00234	0.0226	CbGeAlD
Procainamide—DNMT1—pituitary gland—polycystic ovary syndrome	0.00232	0.0224	CbGeAlD
Procainamide—DNMT1—adipose tissue—polycystic ovary syndrome	0.00231	0.0223	CbGeAlD
Procainamide—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00229	0.033	CcSEcCtD
Procainamide—Lucanthone—TOP2A—polycystic ovary syndrome	0.00222	0.231	CrCbGaD
Procainamide—SCN9A—adrenal gland—polycystic ovary syndrome	0.00211	0.0204	CbGeAlD
Procainamide—SCN4A—pituitary gland—polycystic ovary syndrome	0.00211	0.0204	CbGeAlD
Procainamide—SCN4A—adipose tissue—polycystic ovary syndrome	0.0021	0.0203	CbGeAlD
Procainamide—SCN8A—endocrine gland—polycystic ovary syndrome	0.00208	0.0201	CbGeAlD
Procainamide—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00208	0.03	CcSEcCtD
Procainamide—DNMT1—adrenal gland—polycystic ovary syndrome	0.00207	0.02	CbGeAlD
Procainamide—Neutropenia—Metformin—polycystic ovary syndrome	0.00202	0.0292	CcSEcCtD
Procainamide—SLC22A3—embryo—polycystic ovary syndrome	0.00197	0.0191	CbGeAlD
Procainamide—DNMT1—female gonad—polycystic ovary syndrome	0.00193	0.0187	CbGeAlD
Procainamide—DNMT1—vagina—polycystic ovary syndrome	0.00192	0.0185	CbGeAlD
Procainamide—SCN4A—adrenal gland—polycystic ovary syndrome	0.00188	0.0182	CbGeAlD
Procainamide—SCN2A—pituitary gland—polycystic ovary syndrome	0.00187	0.018	CbGeAlD
Procainamide—SCN10A—pituitary gland—polycystic ovary syndrome	0.0018	0.0174	CbGeAlD
Procainamide—DNMT1—endocrine gland—polycystic ovary syndrome	0.0018	0.0173	CbGeAlD
Procainamide—Bradycardia—Metformin—polycystic ovary syndrome	0.00176	0.0255	CcSEcCtD
Procainamide—ACHE—adrenal gland—polycystic ovary syndrome	0.00168	0.0162	CbGeAlD
Procainamide—SCN3A—pituitary gland—polycystic ovary syndrome	0.00164	0.0158	CbGeAlD
Procainamide—SCN3A—adipose tissue—polycystic ovary syndrome	0.00163	0.0158	CbGeAlD
Procainamide—Flushing—Metformin—polycystic ovary syndrome	0.00161	0.0232	CcSEcCtD
Procainamide—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00161	0.0232	CcSEcCtD
Procainamide—SLC22A4—endometrium—polycystic ovary syndrome	0.00159	0.0153	CbGeAlD
Procainamide—Chills—Metformin—polycystic ovary syndrome	0.00155	0.0224	CcSEcCtD
Procainamide—SCN2A—vagina—polycystic ovary syndrome	0.00155	0.0149	CbGeAlD
Procainamide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00148	0.0213	CcSEcCtD
Procainamide—SCN3A—adrenal gland—polycystic ovary syndrome	0.00147	0.0142	CbGeAlD
Procainamide—SCN2A—endocrine gland—polycystic ovary syndrome	0.00145	0.014	CbGeAlD
Procainamide—SLC22A3—endometrium—polycystic ovary syndrome	0.00144	0.0139	CbGeAlD
Procainamide—SLC22A4—pituitary gland—polycystic ovary syndrome	0.00144	0.0139	CbGeAlD
Procainamide—SLC22A4—adipose tissue—polycystic ovary syndrome	0.00143	0.0138	CbGeAlD
Procainamide—Metoclopramide—CYP17A1—polycystic ovary syndrome	0.00142	0.148	CrCbGaD
Procainamide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0014	0.0202	CcSEcCtD
Procainamide—SCN10A—endocrine gland—polycystic ovary syndrome	0.00139	0.0135	CbGeAlD
Procainamide—SLC22A1—adipose tissue—polycystic ovary syndrome	0.00136	0.0132	CbGeAlD
Procainamide—Malaise—Metformin—polycystic ovary syndrome	0.00136	0.0196	CcSEcCtD
Procainamide—SCN3A—vagina—polycystic ovary syndrome	0.00136	0.0131	CbGeAlD
Procainamide—SCN5A—vagina—polycystic ovary syndrome	0.00135	0.0131	CbGeAlD
Procainamide—SLC22A3—adipose tissue—polycystic ovary syndrome	0.0013	0.0126	CbGeAlD
Procainamide—Myalgia—Metformin—polycystic ovary syndrome	0.00128	0.0185	CcSEcCtD
Procainamide—SLC22A4—adrenal gland—polycystic ovary syndrome	0.00128	0.0124	CbGeAlD
Procainamide—Discomfort—Metformin—polycystic ovary syndrome	0.00127	0.0183	CcSEcCtD
Procainamide—Shock—Metformin—polycystic ovary syndrome	0.00121	0.0175	CcSEcCtD
Procainamide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00121	0.0174	CcSEcCtD
Procainamide—SLC22A4—vagina—polycystic ovary syndrome	0.00119	0.0115	CbGeAlD
Procainamide—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.00118	0.0114	CbGeAlD
Procainamide—Anorexia—Metformin—polycystic ovary syndrome	0.00117	0.0169	CcSEcCtD
Procainamide—SLC22A3—adrenal gland—polycystic ovary syndrome	0.00117	0.0113	CbGeAlD
Procainamide—Hypotension—Metformin—polycystic ovary syndrome	0.00115	0.0166	CcSEcCtD
Procainamide—SLC22A1—vagina—polycystic ovary syndrome	0.00113	0.0109	CbGeAlD
Procainamide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00112	0.0162	CcSEcCtD
Procainamide—SLC22A3—female gonad—polycystic ovary syndrome	0.00109	0.0105	CbGeAlD
Procainamide—SLC22A3—vagina—polycystic ovary syndrome	0.00108	0.0105	CbGeAlD
Procainamide—CHRM2—endocrine gland—polycystic ovary syndrome	0.00108	0.0104	CbGeAlD
Procainamide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00107	0.0154	CcSEcCtD
Procainamide—SLC22A1—endocrine gland—polycystic ovary syndrome	0.00106	0.0102	CbGeAlD
Procainamide—SLC22A5—endometrium—polycystic ovary syndrome	0.00105	0.0101	CbGeAlD
Procainamide—BCHE—endometrium—polycystic ovary syndrome	0.00102	0.00988	CbGeAlD
Procainamide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00101	0.0146	CcSEcCtD
Procainamide—SLC22A3—endocrine gland—polycystic ovary syndrome	0.00101	0.00978	CbGeAlD
Procainamide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00101	0.0145	CcSEcCtD
Procainamide—Urticaria—Metformin—polycystic ovary syndrome	0.000978	0.0141	CcSEcCtD
Procainamide—Abdominal pain—Metformin—polycystic ovary syndrome	0.000973	0.014	CcSEcCtD
Procainamide—SLC22A5—pituitary gland—polycystic ovary syndrome	0.000951	0.00918	CbGeAlD
Procainamide—SLC22A5—adipose tissue—polycystic ovary syndrome	0.000947	0.00914	CbGeAlD
Procainamide—BCHE—uterus—polycystic ovary syndrome	0.000943	0.0091	CbGeAlD
Procainamide—BCHE—pituitary gland—polycystic ovary syndrome	0.000926	0.00894	CbGeAlD
Procainamide—BCHE—adipose tissue—polycystic ovary syndrome	0.000922	0.0089	CbGeAlD
Procainamide—Asthenia—Metformin—polycystic ovary syndrome	0.000883	0.0127	CcSEcCtD
Procainamide—Pruritus—Metformin—polycystic ovary syndrome	0.000871	0.0126	CcSEcCtD
Procainamide—SLC22A5—adrenal gland—polycystic ovary syndrome	0.000849	0.0082	CbGeAlD
Procainamide—Diarrhoea—Metformin—polycystic ovary syndrome	0.000842	0.0122	CcSEcCtD
Procainamide—BCHE—adrenal gland—polycystic ovary syndrome	0.000827	0.00799	CbGeAlD
Procainamide—Dizziness—Metformin—polycystic ovary syndrome	0.000814	0.0118	CcSEcCtD
Procainamide—SLC22A5—female gonad—polycystic ovary syndrome	0.000792	0.00765	CbGeAlD
Procainamide—SLC22A5—vagina—polycystic ovary syndrome	0.000787	0.0076	CbGeAlD
Procainamide—Vomiting—Metformin—polycystic ovary syndrome	0.000783	0.0113	CcSEcCtD
Procainamide—BCHE—vagina—polycystic ovary syndrome	0.000767	0.0074	CbGeAlD
Procainamide—Nausea—Metformin—polycystic ovary syndrome	0.000731	0.0106	CcSEcCtD
Procainamide—BCHE—endocrine gland—polycystic ovary syndrome	0.000717	0.00693	CbGeAlD
Procainamide—CYP2D6—female gonad—polycystic ovary syndrome	0.000511	0.00493	CbGeAlD
Procainamide—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000475	0.00459	CbGeAlD
Procainamide—SCN3A—Axon guidance—IL6—polycystic ovary syndrome	4.38e-05	0.000262	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	4.38e-05	0.000261	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—VEGFA—polycystic ovary syndrome	4.35e-05	0.000259	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—VEGFA—polycystic ovary syndrome	4.35e-05	0.000259	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4.34e-05	0.000259	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	4.3e-05	0.000256	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—YAP1—polycystic ovary syndrome	4.29e-05	0.000256	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—STAR—polycystic ovary syndrome	4.26e-05	0.000254	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.26e-05	0.000254	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.26e-05	0.000254	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HMMR—polycystic ovary syndrome	4.26e-05	0.000254	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	4.25e-05	0.000254	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—IL6—polycystic ovary syndrome	4.21e-05	0.000251	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—IL6—polycystic ovary syndrome	4.21e-05	0.000251	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	4.2e-05	0.00025	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VEGFA—polycystic ovary syndrome	4.19e-05	0.00025	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VEGFA—polycystic ovary syndrome	4.19e-05	0.00025	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SRD5A1—polycystic ovary syndrome	4.17e-05	0.000249	CbGpPWpGaD
Procainamide—ACHE—Metabolism—LHB—polycystic ovary syndrome	4.15e-05	0.000248	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	4.13e-05	0.000246	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NAMPT—polycystic ovary syndrome	4.12e-05	0.000246	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—SCT—polycystic ovary syndrome	4.12e-05	0.000246	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP11A1—polycystic ovary syndrome	4.07e-05	0.000243	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—IL6—polycystic ovary syndrome	4.06e-05	0.000242	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—IL6—polycystic ovary syndrome	4.06e-05	0.000242	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	4.06e-05	0.000242	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HSD3B2—polycystic ovary syndrome	4.06e-05	0.000242	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—IL6—polycystic ovary syndrome	4.04e-05	0.000241	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—SERPINE1—polycystic ovary syndrome	4.04e-05	0.000241	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	4.04e-05	0.000241	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.01e-05	0.000239	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	4.01e-05	0.000239	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	4.01e-05	0.000239	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—LHB—polycystic ovary syndrome	3.99e-05	0.000238	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—STAR—polycystic ovary syndrome	3.97e-05	0.000237	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.97e-05	0.000237	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	3.94e-05	0.000235	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKR1C1—polycystic ovary syndrome	3.93e-05	0.000234	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	3.93e-05	0.000234	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	3.9e-05	0.000233	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKR1C3—polycystic ovary syndrome	3.84e-05	0.000229	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	3.82e-05	0.000228	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.8e-05	0.000227	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMMR—polycystic ovary syndrome	3.8e-05	0.000227	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP17A1—polycystic ovary syndrome	3.78e-05	0.000226	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	3.74e-05	0.000223	CbGpPWpGaD
Procainamide—BCHE—Metabolism—LHB—polycystic ovary syndrome	3.7e-05	0.000221	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.7e-05	0.000221	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.7e-05	0.000221	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	3.66e-05	0.000219	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	3.66e-05	0.000219	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HSD3B1—polycystic ovary syndrome	3.63e-05	0.000216	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	3.62e-05	0.000216	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SULT2A1—polycystic ovary syndrome	3.62e-05	0.000216	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.58e-05	0.000213	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.57e-05	0.000213	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMMR—polycystic ovary syndrome	3.54e-05	0.000211	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	3.5e-05	0.000209	CbGpPWpGaD
Procainamide—ACHE—Metabolism—RRM2—polycystic ovary syndrome	3.5e-05	0.000209	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.48e-05	0.000208	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.46e-05	0.000207	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	3.41e-05	0.000203	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	3.4e-05	0.000203	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HSD3B1—polycystic ovary syndrome	3.38e-05	0.000202	CbGpPWpGaD
Procainamide—ACHE—Metabolism—YAP1—polycystic ovary syndrome	3.38e-05	0.000201	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.36e-05	0.000201	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.33e-05	0.000199	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LHB—polycystic ovary syndrome	3.31e-05	0.000197	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TH—polycystic ovary syndrome	3.27e-05	0.000195	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—IL6—polycystic ovary syndrome	3.27e-05	0.000195	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.27e-05	0.000195	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NAMPT—polycystic ovary syndrome	3.24e-05	0.000193	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	3.23e-05	0.000193	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	3.23e-05	0.000192	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.22e-05	0.000192	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP11A1—polycystic ovary syndrome	3.2e-05	0.000191	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—LEP—polycystic ovary syndrome	3.2e-05	0.000191	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	3.19e-05	0.00019	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—SLC2A4—polycystic ovary syndrome	3.18e-05	0.00019	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.18e-05	0.00019	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	3.13e-05	0.000187	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—IL6—polycystic ovary syndrome	3.13e-05	0.000187	CbGpPWpGaD
Procainamide—BCHE—Metabolism—RRM2—polycystic ovary syndrome	3.12e-05	0.000186	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LHB—polycystic ovary syndrome	3.08e-05	0.000184	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKR1C3—polycystic ovary syndrome	3.02e-05	0.00018	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	3.01e-05	0.00018	CbGpPWpGaD
Procainamide—BCHE—Metabolism—YAP1—polycystic ovary syndrome	3.01e-05	0.00018	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—polycystic ovary syndrome	3.01e-05	0.000179	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—polycystic ovary syndrome	3.01e-05	0.000179	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP19A1—polycystic ovary syndrome	2.99e-05	0.000179	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP17A1—polycystic ovary syndrome	2.98e-05	0.000178	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.98e-05	0.000177	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	2.95e-05	0.000176	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	2.92e-05	0.000174	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.9e-05	0.000173	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—polycystic ovary syndrome	2.9e-05	0.000173	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—polycystic ovary syndrome	2.9e-05	0.000173	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	2.9e-05	0.000173	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	2.9e-05	0.000173	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	2.89e-05	0.000173	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	2.88e-05	0.000172	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.88e-05	0.000172	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	2.86e-05	0.00017	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	2.86e-05	0.00017	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	2.85e-05	0.00017	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.84e-05	0.000169	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	2.79e-05	0.000166	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—POMC—polycystic ovary syndrome	2.75e-05	0.000164	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—INS—polycystic ovary syndrome	2.73e-05	0.000163	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	2.71e-05	0.000162	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	2.7e-05	0.000161	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	2.69e-05	0.00016	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	2.68e-05	0.00016	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GNAS—polycystic ovary syndrome	2.67e-05	0.000159	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	2.66e-05	0.000158	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	2.65e-05	0.000158	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.64e-05	0.000158	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	2.64e-05	0.000158	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.63e-05	0.000157	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	2.6e-05	0.000155	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	2.58e-05	0.000154	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TH—polycystic ovary syndrome	2.58e-05	0.000154	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	2.55e-05	0.000152	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.55e-05	0.000152	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NCOR1—polycystic ovary syndrome	2.54e-05	0.000152	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	2.51e-05	0.00015	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SLC2A4—polycystic ovary syndrome	2.51e-05	0.000149	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.48e-05	0.000148	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	2.45e-05	0.000146	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	2.44e-05	0.000145	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.43e-05	0.000145	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	2.42e-05	0.000144	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP1A1—polycystic ovary syndrome	2.41e-05	0.000144	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	2.41e-05	0.000144	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	2.41e-05	0.000144	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.4e-05	0.000143	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.39e-05	0.000142	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	2.38e-05	0.000142	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	2.37e-05	0.000142	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	2.36e-05	0.000141	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	2.36e-05	0.000141	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP19A1—polycystic ovary syndrome	2.36e-05	0.000141	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.3e-05	0.000137	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.3e-05	0.000137	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TH—polycystic ovary syndrome	2.3e-05	0.000137	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTHFR—polycystic ovary syndrome	2.25e-05	0.000134	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.25e-05	0.000134	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	2.24e-05	0.000133	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.23e-05	0.000133	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.23e-05	0.000133	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.21e-05	0.000132	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	2.21e-05	0.000132	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.2e-05	0.000131	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.18e-05	0.00013	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.11e-05	0.000126	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GNAS—polycystic ovary syndrome	2.1e-05	0.000125	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	2.1e-05	0.000125	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	2.07e-05	0.000124	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	2.05e-05	0.000123	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TH—polycystic ovary syndrome	2.05e-05	0.000122	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	2.04e-05	0.000122	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.02e-05	0.000121	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NCOR1—polycystic ovary syndrome	2e-05	0.00012	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	2e-05	0.000119	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	1.96e-05	0.000117	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	1.92e-05	0.000114	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TH—polycystic ovary syndrome	1.91e-05	0.000114	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP1A1—polycystic ovary syndrome	1.9e-05	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	1.89e-05	0.000113	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.88e-05	0.000112	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GNAS—polycystic ovary syndrome	1.88e-05	0.000112	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	1.87e-05	0.000111	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.86e-05	0.000111	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—polycystic ovary syndrome	1.82e-05	0.000109	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	1.81e-05	0.000108	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POMC—polycystic ovary syndrome	1.8e-05	0.000107	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—INS—polycystic ovary syndrome	1.79e-05	0.000107	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	1.79e-05	0.000107	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—polycystic ovary syndrome	1.77e-05	0.000106	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.75e-05	0.000104	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.72e-05	0.000102	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.7e-05	0.000102	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	1.69e-05	0.000101	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.69e-05	0.000101	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	1.68e-05	0.0001	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	1.67e-05	9.99e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.66e-05	9.93e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.61e-05	9.61e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	1.6e-05	9.52e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	1.58e-05	9.42e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	1.56e-05	9.32e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	1.56e-05	9.28e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	1.56e-05	9.28e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.51e-05	9.03e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.5e-05	8.94e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	1.49e-05	8.88e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	1.48e-05	8.86e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.48e-05	8.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.45e-05	8.64e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.44e-05	8.6e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.44e-05	8.57e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—polycystic ovary syndrome	1.44e-05	8.56e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—polycystic ovary syndrome	1.42e-05	8.45e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	1.41e-05	8.42e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.41e-05	8.41e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—INS—polycystic ovary syndrome	1.41e-05	8.4e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.38e-05	8.26e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	1.37e-05	8.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	1.36e-05	8.12e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	1.36e-05	8.1e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.33e-05	7.93e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	1.31e-05	7.84e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.31e-05	7.84e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.31e-05	7.81e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.29e-05	7.69e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—polycystic ovary syndrome	1.28e-05	7.64e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—polycystic ovary syndrome	1.26e-05	7.54e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—INS—polycystic ovary syndrome	1.26e-05	7.49e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.24e-05	7.4e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.22e-05	7.29e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	1.19e-05	7.13e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	1.14e-05	6.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.14e-05	6.79e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	1.13e-05	6.73e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—INS—polycystic ovary syndrome	1.12e-05	6.69e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.12e-05	6.66e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	1.07e-05	6.36e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.06e-05	6.3e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	1.05e-05	6.27e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—INS—polycystic ovary syndrome	1.05e-05	6.24e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.03e-05	6.13e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	9.66e-06	5.77e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	9.57e-06	5.71e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	9.36e-06	5.59e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	8.63e-06	5.15e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	8.35e-06	4.98e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	8.22e-06	4.9e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	8.04e-06	4.8e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	8e-06	4.77e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	7.79e-06	4.65e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	7.74e-06	4.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	7.73e-06	4.61e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.35e-06	4.38e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	7.26e-06	4.33e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	5.92e-06	3.53e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.89e-06	3.51e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	5.81e-06	3.46e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.78e-06	3.45e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.05e-06	3.01e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	3.5e-06	2.09e-05	CbGpPWpGaD
